A controlled trial of azapropazone in tinnitus.
A single-blind placebo-controlled trial of azapropazone, a non-steroidal anti-inflammatory drug, is presented in 10 patients with tinnitus. Seventeen variables were assessed by questionnaire and six by a daily diary. In none of these was there a significant difference between placebo and drug. A larger trial is probably therefore not justified.
Stoney
P J
PJ
ENT Department, University Hospital of Wales, Cardiff.
Callaghan
D E
DE
Walker
F S
FS
Stephens
S D
SD
D001032:Apazone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008499:Medical Records; D016037:Single-Blind Method; D011795:Surveys and Questionnaires; D014012:Tinnitus / Q000188:drug therapy*
D001032:Apazone